Regulation of in vitro glia‐induced microvessel morphogenesis by urokinase

Journal of Cellular Physiology

Volumn 158, Issue 2, 1994, Pages 317-324

  Laterra, John ^a,b   Indurti, Ravi R ^a,b   Goldstein, Gary W ^a,b  

^a Kaiser Permanente   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; PLASMINOGEN ACTIVATOR; TRYPSIN INHIBITOR;

ANIMAL CELL; ARTICLE; BRAIN MICROCIRCULATION; CATTLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIA CELL; MORPHOGENESIS; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL;

ANIMAL; CAPILLARIES; CATTLE; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; NEUROGLIA; PEPTIDE FRAGMENTS; PLASMIN; RATS; RETINAL VESSELS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA; BOS TAURUS; GLYCINE MAX;

EID: 0028097632     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.1041580214     Document Type: Article

References (53)

1. Medroxyprogesterone acetate, an anti‐cancer and antiangiogenic steroid inhibits the plasminogen activator in bovine endothelial cells
2. The blood‐retinal barrier and vaso‐glial relationships in retinal disease
3. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis
4. Differentiated rat glial cell stain in tissue culture
5. In vitro studies on the mode of action of the phorbol esters, potent tumor promoters. Part I. CRC Crit
6. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding
7. Allografts of CNS tissue possess a blood‐brain barrier. II. Angiogenesis in solid tissue and cell suspension grafts
8. Development of the blood vessels and extrcaellular spaces during postnatal maturation of rat cerebral cortex
9. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin‐1
10. Protease nexin‐1. Localization in the humar brain suggests a protective role against extravasated serine proteases
11. Mechanisms of angiogenesis
12. Gamma‐glutamyl transpeptidase in isolated brain endothelial cells: induction by glial cells in vitro
13. Plasminogen activators and their inhibitors in the neuromuscular system: I. Developmental regulation of plasminogen activator isoforms during in vitro myogenesis in two cell lines
14. Immunohistochemical localization of tissue plasminogen activator in human brain tumors
15. Biochemistry of aprotinin and aprotinin‐like inhibitors
16. Plasminogen activator production by human retinal endothelial cells of nondiabetic and diabetic origin
17. Immunocytochemical localization of glia‐derived nexin, laminin and fibronectin on the surface or extracellular matrix of C6 rat glioma cells, astrocytes and fibroblasts
18. Astrocytes induce blood‐brain barrier properties in endothelial cells
19. A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue‐type activators
20. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary‐like structures
21. Regulation of gene expression by SPARC during angiogenesis in vitro
22. Astroglial‐induced in vitro angiogenesis: Requirements for RNA and protein synthesis
23. Astrocytes induce neural microvascular endothelial cells to form capillary‐like structures in vitro
24. Inhibition of astroglia‐induced endothelial differentiation by inorganic lead: A role for protein kinase C
25. Stimulation and desensitization of tissue plasminogen activator release from human endothelial cells
26. Modulation of granule cell migration by a glia‐derived protein
27. The development of astrocytes in the cat retina: Evidence of migration from the optic nerve
28. Organizational behavior of human umbilical vein endothelial cells
29. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose
30. In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor‐induced proteinases
31. Tumor‐promoting phorbol esters induce angiogenesis in vitro
32. Modulation of plasminogen activator and plasminogen activator inhibitor expression in the human U373 glioblastoma/astrocytoma cell line by inflammatory mediators
33. Tumor necrosis factor induction of urokinase‐type plasminogen activator in human endothelial cells
34. An autocrine role for urokinase in phorbol ester‐mediated differentiation of myeloid cell lines
35. Transforming growth factor‐beta 1 modulates basic fibroblast growth factor‐induced proteolytic and angiogenic properties of endothelial cells in vitro
36. 1 on in vitro angiogenesis
37. Structural requirements for the growth factor activity of the amino‐terminal domain of urokinase
38. The involvement of proteases and protease inhibitors in neovascularization
39. Identification of a protease inhibitor produced by astrocytes that is structurally and functionally homologous to human protease nexin‐I
40. Immunocytochemical expression of the endothelial barrier antigen (EBA) during brain angiogenesis
41. A cell culture model of the blood‐brain barrier
42. Cell‐associated plasminogen activation: Regulation and physiologic functions
43. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells
44. Indispensable role of tissue‐type plasminogen activator in growth factor‐dependent tube formation of human microvascular endothelial cells in vitro
45. Developing nervous tissue induces formation of blood‐brain barrier characteristics in invading endothelial cells: a study using quail‐chick transplantation chimeras
46. Axonal degeneration associated with a defective blood brain barrier in cerebral implants
47. Tight junctions of brain endothelium in vitro are enhanced by astroglia
48. Amiloride selectively inhibits the urokinase‐type plasminogen activator
49. Identitification and isolation of endothelial cells based on their increased uptake of acetaylated–low density lipoprotein
50. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay
51. Steroid inhibition of neural microvessel morphogenesis in vitro: Receptor mediation and astroglial dependence
52. Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors